Finkelstein J J

Regenerx Biopharmaceuticals Inc.

President and CEO, Director

Avg. Two Year Performance

(24%) Avg. Purchase Return (11%) Compound

46% Avg. Sale Return 21% Compound

Holdings: 1.64M shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions